Published works from the Kiss RNA Lab

(Kiss RNA Lab members underlined, Dr. Kiss in bold)

1. Damase, T., Zhang, M., Sukhovershin, R. S., Kiss, D.L., and Cooke, J.P., Hospital-Based RNA Therapeutics, Messenger RNA Therapeutics Book chapter, Springer/Nature. (Accepted and in Press)

– A preprint of the above peer-reviewed book chapter before copy editing is available via this link.

2. Tat, T.; Kiss, D.L. (2021) From m6A to Cap-Adjacent m6Am and Their Effects on mRNAs. In: Jurga S., Barciszewski J. (eds) Epitranscriptomics. RNA Technologies, vol 12. Springer, Cham.

– A preprint of the above peer-reviewed book chapter prior to peer review and before copy editing. Please note, this preprint includes a significantly expanded reference list which includes ~100 additional references that were deleted during the revision process.

3. Berger MR, Alvarado R, Kiss, D.L., mRNA 5′ ends targeted by cytoplasmic recapping cluster at CAGE tags and select transcripts are alternatively spliced. FEBS Lett. 2019 Apr;593(7):670-679. PMID: 30810230 *Editor’s Choice selection

– Follow this Youtube link for a ~30 minute live-streamed presentation of this work.

Submitted works from the Kiss RNA Lab

Bejar,N.#, Tat, T.#, and Kiss, D.L., RNA therapeutics – the next generation of drugs for cardiovascular diseases; Invited Review., Current Atherosclerosis Reports (Submitted November 4, 2021) # these authors contributed equally.

The following link is for a preprint of the above review (prior to a peer-review) is available.

Yu, Y.#, Alvarado, R.#, Petty, L., Bohlender, RL., Shaw, DM., Below, JE., Bejar, N., Ruiz, O., Eisenhoffer, GT., Kiss, D.L., Huff, CD., Letra, A., Hecht, JT. Polygenic risk impacts PDGFRA mutation penetrance in nonsyndromic cleft lip and palate. (Revision submitted to Human Molecular Genetics since January 10, 2022).  # these authors contributed equally.

Published works from Dr. Kiss’s postdoc:

    1. Kiss, D.L., Baez, W.D., Bundschuh, R.A., Huebner, K, and Schoenberg D.R. (2018) Loss of Fragile Histidine Triad (Fhit) protein expression alters the translation of cancer-associated mRNAs. BMC Res Notes. 2018/Mar 14;11(1):178. PMID: 29540221 
    1. Kiss, D.L., Baez, W.D., Bundschuh, R.A., Huebner, K, and Schoenberg D.R. (2017) Impact of Fhit on the translation of cancer-associated mRNAs. Molecular Cancer. Dec 28;16(1):179.  PMID: 29282095
    1. Kiss, D.L., Waters, C.E., Ouda, I.M., Saldivar, J.C., Karras, J.R., Amin, Z.A., Mahrous, S., Druck, T., Bundschuh, R.A., Huebner, K and D.R. Schoenberg. (2017) Identification of Fhit as a Post-transcriptional Effector of Thymidine Kinase 1 Expression. BBA Gene Regulatory Mechanisms. Jan 14;1860(3):374-38. PMID: 28093273
    1. Kiss, D.L., Oman, K., Dougherty, J., Mukherjee, C.M., Bundschuh, R., and D.R. Schoenberg, (2016) Cap homeostasis is independent of poly(A) tail length. Nucl Acids Res. Jan 8;44(1):304-14. ; PMID: 26673707 
    1. Kiss, D.L., Oman, K., Bundschuh, R., and D.R. Schoenberg, (2015) Uncapped 5’ ends of mRNAs targeted by cytoplasmic capping map to the vicinity of downstream CAGE tags. FEBS Lett. Jan 30;589(3):279-84. PMID: 25541487
View All Publications